-
FATE Dashboard
- Financials
- Filings
-
Holdings
- Transcripts
- ETFs
- Insider
- Institutional
- Shorts
Fate Therapeutics (FATE)
Company Profile
Quarter (USD) | Sep 24 | Jun 24 | Mar 24 | Dec 23 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Annual (USD) | Dec 23 | Dec 22 | Dec 21 | Dec 20 | |
---|---|---|---|---|---|
Revenue | |||||
Cost of revenue | |||||
Operating income | |||||
Operating margin | |||||
Net income | |||||
Net profit margin | |||||
Cash on hand | |||||
Change in cash | |||||
Diluted EPS |
Cash burn rate (est.) | Burn method: Change in cash | Burn method: Operating income | Burn method: FCF (opex + capex) | Last Q | Avg 4Q | Last Q | Avg 4Q | Last Q | Avg 4Q |
---|---|---|---|---|---|---|
Cash on hand (at last report) | 48.14 mm | 48.14 mm | 48.14 mm | 48.14 mm | 48.14 mm | 48.14 mm |
Cash burn (monthly) | 1.32 mm | 31.25 k | 17.46 mm | 16.38 mm | 9.81 mm | 10.98 mm |
Cash used (since last report) | 5.41 mm | 128.20 k | 71.62 mm | 67.21 mm | 40.23 mm | 45.03 mm |
Cash remaining | 42.72 mm | 48.01 mm | -23.49 mm | -19.08 mm | 7.91 mm | 3.11 mm |
Runway (months of cash) | 32.4 | 1536.2 | -1.3 | -1.2 | 0.8 | 0.3 |
13F holders | Current |
---|---|
Total holders | 161 |
Opened positions | 22 |
Closed positions | 38 |
Increased positions | 42 |
Reduced positions | 59 |
13F shares | Current |
---|---|
Total value | 391.61 bn |
Total shares | 114.64 mm |
Total puts | 9.00 k |
Total calls | 53.70 k |
Total put/call ratio | 0.2 |
Largest owners | Shares | Value |
---|---|---|
Redmile | 13.17 mm | $46.09 bn |
BlackRock | 10.47 mm | $36.66 bn |
Vanguard | 10.40 mm | $36.41 bn |
Deep Track Capital | 5.57 mm | $19.50 bn |
STT State Street | 5.25 mm | $18.39 bn |
Boxer Capital | 4.96 mm | $17.36 bn |
BLVGF Bellevue | 4.84 mm | $16.94 bn |
Citadel Advisors | 4.28 mm | $14.99 bn |
Deerfield Management | 3.56 mm | $12.45 bn |
JNJ Johnson & Johnson | 3.38 mm | $11.83 bn |
Date | Owner | Security | Transaction | Code | Indirect | 10b5-1 | $Price | #Shares | $Value | #Remaining |
---|---|---|---|---|---|---|---|---|---|---|
16 Jan 25 | Bahram Valamehr | Stock Option Common Stock | Grant | Acquire A | No | No | 1.25 | 1,300,000 | 1.63 mm | 1,300,000 |
15 Jan 25 | Cindy Tahl | Common Stock | Grant | Acquire A | No | No | 0 | 70,000 | 0.00 | 406,707 |
15 Jan 25 | Cindy Tahl | Stock Option Common Stock | Grant | Acquire A | No | No | 1.32 | 275,000 | 363.00 k | 275,000 |
15 Jan 25 | Jerome Charles Bressi | Common Stock | Grant | Acquire A | No | No | 0 | 65,000 | 0.00 | 335,203 |
15 Jan 25 | Jerome Charles Bressi | Stock Option Common Stock | Grant | Acquire A | No | No | 1.32 | 250,000 | 330.00 k | 250,000 |
10 Jan 25 | Cindy Tahl | Common Stock | Sell | Dispose S | No | No | 1.55 | 5,654 | 8.76 k | 336,707 |
10 Jan 25 | Jerome Charles Bressi | Common Stock | Sell | Dispose S | No | No | 1.55 | 5,980 | 9.27 k | 270,203 |